Sodium-Glucose Cotransporter-2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Discontinuation in Patients with CKD.
L Parker GreggPeter A RichardsonVijay NambiLaura A PetersenMichael E MathenySalim S ViraniSankar D NavaneethanPublished in: Journal of the American Society of Nephrology : JASN (2024)
SGLT2 inhibitor and GLP-1 RA discontinuation was common and associated with harmful outcomes in adults with CKD.